MKC-1106-NS

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMKC-1106-NS
Drug Alias NameNy-ESO-1 Modulator (MannKind)MKC-1106-NS
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Recombinant polypeptide +[4] 
Mechanisms of ActionSSX Family Member 2 inhibitorsCancer/testis antigen 1 modulators
TargetsSSX Family Member 2Cancer/testis antigen 1
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesColby Pharmaceutical CoMannKind Corp
Active IndicationsN/A
Inactive IndicationsHematologic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A